W

Walvax Biotechnology Co Ltd
SZSE:300142

Watchlist Manager
Walvax Biotechnology Co Ltd
SZSE:300142
Watchlist
Price: 12.76 CNY -2.45% Market Closed
Market Cap: 20.4B CNY
Have any thoughts about
Walvax Biotechnology Co Ltd?
Write Note

Relative Value

The Relative Value of one Walvax Biotechnology Co Ltd stock under the Base Case scenario is 22.83 CNY. Compared to the current market price of 12.76 CNY, Walvax Biotechnology Co Ltd is Undervalued by 44%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

Relative Value
Base Case
22.83 CNY
Undervaluation 44%
Relative Value
Price
W
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
82
vs Industry
64
Median 3Y
9.1
Median 5Y
20.3
Industry
7.6
Forward
6.5
vs History
19
vs Industry
3
Median 3Y
99.7
Median 5Y
107.8
Industry
22.1
Forward
50.7
vs History
84
vs Industry
8
Median 3Y
36.6
Median 5Y
88.2
Industry
21.9
vs History
28
vs Industry
4
Median 3Y
74.2
Median 5Y
-135.5
Industry
23.4
vs History
87
vs Industry
44
Median 3Y
5
Median 5Y
8.8
Industry
2.5
vs History
80
vs Industry
59
Median 3Y
8.4
Median 5Y
19.6
Industry
7.5
Forward
5.7
vs History
77
vs Industry
57
Median 3Y
10.1
Median 5Y
22.2
Industry
9.3
vs History
57
vs Industry
6
Median 3Y
44.1
Median 5Y
56.5
Industry
4.2
Forward
16.1
vs History
57
vs Industry
6
Median 3Y
44.1
Median 5Y
56.5
Industry
4
Forward
22.3
vs History
79
vs Industry
9
Median 3Y
34.2
Median 5Y
84.2
Industry
5.9
vs History
9
vs Industry
0
Median 3Y
219.5
Median 5Y
-143.4
Industry
3.9
vs History
87
vs Industry
51
Median 3Y
5.4
Median 5Y
8
Industry
4.5

Multiples Across Competitors

Competitors Multiples
Walvax Biotechnology Co Ltd Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
CN
Walvax Biotechnology Co Ltd
SZSE:300142
20.5B CNY 6.1 152.1 42.3 42.3
FR
Pharnext SCA
OTC:PNEXF
6T USD 38 027 714.7 -180 740.1 -219 476 -216 971.5
US
Abbvie Inc
NYSE:ABBV
310.2B USD 5.6 61 15.2 23.4
US
Amgen Inc
NASDAQ:AMGN
142B USD 4.4 33.4 16.1 30.5
US
Gilead Sciences Inc
NASDAQ:GILD
115B USD 4.1 910 10.1 10.1
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
101.6B USD 9.5 -211.2 20.8 21.9
US
Epizyme Inc
F:EPE
94.1B EUR 1 852.6 -472.7 -514.8 -501.1
AU
CSL Ltd
ASX:CSL
134.4B AUD 5.7 31.8 19.7 24.6
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
78.5B USD 5.6 16.8 15.3 17
US
Seagen Inc
F:SGT
39.3B EUR 17.8 -54.7 -58.8 -53
NL
argenx SE
XBRU:ARGX
36B EUR 19.3 -135.6 -109.5 -79.8
P/S Multiple
Revenue Growth P/S to Growth
CN
W
Walvax Biotechnology Co Ltd
SZSE:300142
Average P/S: 3 457 240.5
6.1
4%
1.4
FR
Pharnext SCA
OTC:PNEXF
38 027 714.7
N/A N/A
US
Abbvie Inc
NYSE:ABBV
5.6
20%
0.3
US
Amgen Inc
NASDAQ:AMGN
4.4
26%
0.2
US
Gilead Sciences Inc
NASDAQ:GILD
4.1
10%
0.4
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
9.5
34%
0.3
US
E
Epizyme Inc
F:EPE
1 852.6
N/A N/A
AU
CSL Ltd
ASX:CSL
5.7
23%
0.2
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
5.6
23%
0.2
US
S
Seagen Inc
F:SGT
17.8
118%
0.2
NL
argenx SE
XBRU:ARGX
19.3
220%
0.1
P/E Multiple
Earnings Growth P/E to Growth
CN
W
Walvax Biotechnology Co Ltd
SZSE:300142
Average P/E: 200.8
152.1
112%
1.4
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -180 740.1 N/A N/A
US
Abbvie Inc
NYSE:ABBV
61
413%
0.1
US
Amgen Inc
NASDAQ:AMGN
33.4
73%
0.5
US
Gilead Sciences Inc
NASDAQ:GILD
910
77%
11.8
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Negative Multiple: -211.2
48%
N/A
US
E
Epizyme Inc
F:EPE
Negative Multiple: -472.7 N/A N/A
AU
CSL Ltd
ASX:CSL
31.8
65%
0.5
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
16.8
44%
0.4
US
S
Seagen Inc
F:SGT
Negative Multiple: -54.7 N/A N/A
NL
argenx SE
XBRU:ARGX
Negative Multiple: -135.6 N/A N/A
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
CN
W
Walvax Biotechnology Co Ltd
SZSE:300142
Average EV/EBITDA: 19.9
42.3
113%
0.4
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -219 476 N/A N/A
US
Abbvie Inc
NYSE:ABBV
15.2
29%
0.5
US
Amgen Inc
NASDAQ:AMGN
16.1
62%
0.3
US
Gilead Sciences Inc
NASDAQ:GILD
10.1
16%
0.6
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
20.8
43%
0.5
US
E
Epizyme Inc
F:EPE
Negative Multiple: -514.8 N/A N/A
AU
CSL Ltd
ASX:CSL
19.7
42%
0.5
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
15.3
35%
0.4
US
S
Seagen Inc
F:SGT
Negative Multiple: -58.8 N/A N/A
NL
argenx SE
XBRU:ARGX
Negative Multiple: -109.5 N/A N/A
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
CN
W
Walvax Biotechnology Co Ltd
SZSE:300142
Average EV/EBIT: 24.3
42.3
79%
0.5
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -216 971.5 N/A N/A
US
Abbvie Inc
NYSE:ABBV
23.4
90%
0.3
US
Amgen Inc
NASDAQ:AMGN
30.5
90%
0.3
US
Gilead Sciences Inc
NASDAQ:GILD
10.1
32%
0.3
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
21.9
45%
0.5
US
E
Epizyme Inc
F:EPE
Negative Multiple: -501.1 N/A N/A
AU
CSL Ltd
ASX:CSL
24.6
54%
0.5
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
17
42%
0.4
US
S
Seagen Inc
F:SGT
Negative Multiple: -53 N/A N/A
NL
argenx SE
XBRU:ARGX
Negative Multiple: -79.8 N/A N/A

See Also

Discover More
Back to Top